openPR Logo
Press release

Renal Biomarkers Market Booming by Size, Revenue and Trend in 2019

06-18-2019 08:35 PM CET | Health & Medicine

Press release from: Allied Market Research

Renal Biomarkers Market

Renal Biomarkers Market

Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.

Download the Sample Report @ http://bit.ly/2WPpJBJ

There is an impending need for specific and sensitive biomarkers that can identify kidney diseases at the earliest. The early identification helps to take timely preventive steps, before the damage becomes irreversible. The major factors fuelling the global renal biomarkers market are; increased incidence of kidney diseases, large geriatric population and increasing prevalence of multiple co-morbidities.

The market would also gain prominence due to rising incidences of chronic diseases such as diabetes, obesity and hypertension, as these diseases are often associated with the gradual loss of kidney function. Furthermore, increasing investments in research and development will further drive the market, as renal biomarkers are widely used in preclinical and clinical trials, to assess the safety of new drugs. However, lack of transparent reimbursement and regulatory scenario, especially, in the developing countries, is likely to restrain the market.

The global renal biomarkers market is segmented on the basis of marker type, assay platform, application and geography. On the basis of marker type, the market is segmented into Creatinine, Blood urea nitrogen (BUN), Cystatin C, Neutrophil gelatinise-associated lipocalin (NGAL). It is further segmented into other markers such as N-Acetyl-β-D-Glucosaminidase (NAG), Kidney Injury Molecule 1 (Kim1), TIMP-2, L-FABP, Interleukin-18 and Clusterin. The market is segmented on the basis of assay platform type into, Enzyme Linked Immunosorbent Assay (ELISA) and Turbidimetric Immunoassay which includes Particle-Enhanced Turbidimetric Immunoassay (PETIA). The market further segments into other assay types such as Chemiluminescent Immunoassay (CLIA) and fluorescence immunoassay. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.

Few of the strategies adopted by key industrial players are collaborations, FDA approvals and distribution agreements. For instance, recently, the International Society of Nephrology (ISN) with the support of industry players, has launched, 0by25, a human right initiative to neutralize the count of deaths arising from acute kidney injury, worldwide, by 2025. In Sep 2014, FDA approved Astute Medical’s NephroCheck, the first diagnostic test for acute kidney injury. The company also entered into a marketing and development agreement with BioMérieux, allowing the use of NephroCheck on VIDAS immunoassay system. The companies profiled in the report include, Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Astute Medical Inc., Alere Inc., bioMérieux SA and Randox Laboratories Ltd.

For More Inquiry @ http://bit.ly/2XVSuZL

KEY MARKET BENEFITS
• Comprehensive analysis of factors that drive and restrict the growth of the global renal biomarkers market is provided.
• The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014‐2020, which would enable the stakeholders to capitalize on prevailing market opportunities.
• An in-depth analysis of key segments of the market demonstrate the types of markers and assay platforms that are currently being used along with the variants that would gain prominence in future.
• SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.
• Region-wise renal biomarkers market conditions are comprehensively analyzed in the report.
• Competitive intelligence highlights the business practises followed by leading market players across the geographies.

The global renal biomarkers market is segmented below:
Global Renal Biomarkers Market ‐ By Marker Type
Creatinine
Blood urea nitrogen (BUN)
Cystatin C
Neutrophil gelatinase-associated lipocalin (NGAL)
Others
N-Acetyl-β-D-Glucosaminidase (NAG)
Kidney Injury Molecule 1 (Kim1)
TIMP-2 (TIMP metallopeptidase inhibitor 2)
Liver-Type Fatty Acid-Binding Protein (L-FABP)
Interleukin-18 (IL-18)
Clusterin

Global Renal Biomarkers Market ‐ By Assay Platform Type:
Enzyme Linked Immunosorbent Assay (ELISA)
Enzymatic Assay
Turbidimetric Immunoassay
Particle-Enhanced Turbidimetric Immunoassay (PETIA)
Others
Chemiluminescent Immunoassay (CLIA)
Fluorescence Immunoassay

Global Renal Biomarkers Market ‐ By Application
Diagnosis and disease progression monitoring
Research

Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Biomarkers Market Booming by Size, Revenue and Trend in 2019 here

News-ID: 1779985 • Views: 215

More Releases from Allied Market Research

Overview Membrane Technology for Food and Beverage Processing Market Size, Share …
Membranes are natural or manufactured substances used for separation. They commonly serve the purpose of filter pads. Membranes, which are semi-permeable in nature (allow only selective compounds/substances to flow pass them) are easy to manufacture. These are gaining popularity in the process industry where purity of products is highly desired. Membranes are available in every shape and size and are required in numerous devices right from the water filter at
Cooking Appliances Market is Predicted to Grow High CAGR from 2019 to 2026
The cooking appliance include products such as microwaves, ovens, cook tops, and range hoods. Modern cooking appliance are used to provide ease to chefs. Also, with rapid depletion of natural resources such as LPG, and other petroleum products, there is an urgent need to use efficient and eco-friendly cooking appliances in kitchen. Key players are developing advance cooking appliances in order to increase their market share, and on the same
Power Bank Market Insights with Statistics and Growth Prediction 2018 to 2025
The growth of the global power bank market is driven by rising in demand for smartphones across the globe and an increase in sales of power banks on online portals & e-commerce websites. However, factors such as emerging trends of wireless charging and improved battery capacity of electronic devices hamper market growth. On the other hand, the development of solar & hydrogen fuel-based power banks and an increase in the
Shale Gas Market 2022 | Business Analysis and Evolutionary Growth
Shale gas is emerging as an ideal energy source, owing to its abundance, low carbon footprint and comparatively low price than conventional energy source such as natural gas, coal, nuclear and hydro. However, the issue of water scarcity due to the hydraulic fracturing technique may hamper its production. Moreover, the unstructured regulatory framework in the European countries may dampen its producers to some extent. The global shale gas consumption is

All 5 Releases


More Releases for Renal

Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report
Renal Insufficiency Market Vendor Growth Landscape 2025
Global Renal Insufficiency Market: Snapshot The demand for renal disease treatment products and therapies has been incrementing steadily in the past few years, owing to the prevalence of poor kidney functions among a vast population base across the world, especially in the Asia Pacific region, and increased government support. However, the participants of the global renal insufficiency market must take a note of weak competition among the marketed products for the
Acute Renal Failure - Pipeline Review, H1 2018
"The Report Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Acute Renal Failure Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)
Renal Diseases Pharmaceutical and Healthcare Analysis Information
Pune, India, 9th November 2017: WiseGuyReports announced addition of new report, titled “Frontier Pharma: Renal Diseases - High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for”. Summary The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the
Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report
Renal Cluster Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title Renal Cluster Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports. This report provides an overview of the renal cluster pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Kidney Fibrosis, Chronic Kidney Disease (Chronic Renal Failure), Acute Renal Failure (ARF), Kidney Transplant Rejection, and